Neuralink has dominated the brain-chip story for two years. It now has a serious challenger with a patient of its own. Paradromics, an Austin neurotech firm, has implanted its Connexus brain-computer interface in the first participant of its FDA-approved clinical study, the company said. The patient, a Michigan woman who has lost the ability to […]

This story continues at The Next Web